Target ALS
  • NEWS
  • DONATE
  • ABOUT US
    • CHALLENGE
    • OUR APPROACH
    • OUR IMPACT
    • ABOUT ALS
  • RESOURCES FOR SCIENTISTS
    • HUMAN POSTMORTEM TISSUE CORE
    • GENOMIC DATASETS
    • STEM CELL CORE
    • ANIMAL MODELS
    • IN VIVO TARGET VALIDATION CORE
    • VIRAL VECTOR CORE
    • ANTIBODY CORE
    • LONGITUDINAL BIOFLUIDS CORE
  • RESEARCH
    • FUNDED CONSORTIA
    • ANNUAL MEETING
    • PUBLICATIONS
  • FUNDING OPPORTUNITIES
  • COMMUNITY
    • FOUNDER
    • LEADERSHIP
    • SCIENTISTS
    • SPRINGBOARD FELLOWS
    • PARTNERS
  • TAKE ACTION
    • CONTACT US
    • EMAIL SIGN UP
    • DONATE NOW
    • WAYS TO GIVE
Select Page
ALS Charity Gets Creative During COVID-19 By Taking On ‘The Toughest Challenge’

ALS Charity Gets Creative During COVID-19 By Taking On ‘The Toughest Challenge’

by Target ALS | Oct 19, 2020 | Fundraising

Join Target ALS as they team with Spartan to raise ALS awareness and funds for medical research during this difficult time. Learn the details, sign up, and get started at www.toughestchallenge.com.    Written by Josh Hall Life has changed in our new COVID-19...
Under the Microscope: Sophie Parmentier-Batteur on Interrogating a Protein Compound for Possible Therapeutic Approaches to ALS and FTD

Under the Microscope: Sophie Parmentier-Batteur on Interrogating a Protein Compound for Possible Therapeutic Approaches to ALS and FTD

by Target ALS | Jun 8, 2020 | Changemakers

Earlier this month, Target ALS and The Association for Frontotemporal Degeneration (AFTD) announced six teams who will receive a portion of $5 million in funding for projects targeting the discovery of treatments and biomarkers* for ALS and FTD. Though FTD represents...
UNDER THE MICROSCOPE: Ludo Van Den Bosch on Returning to Work, Exploring Therapeutic Strategies to Battle ALS & FTD

UNDER THE MICROSCOPE: Ludo Van Den Bosch on Returning to Work, Exploring Therapeutic Strategies to Battle ALS & FTD

by Target ALS | Jun 2, 2020 | Collaboration

As the world begins the restoration project that is life after COVID-19, a major challenge will be establishing means to carefully return to daily activities. For Ludo Van Den Bosch of the Belgium-based Flanders Institute for Biotechnology (VIB), that means proceeding...
Searching for Information, a Media Resource Offers Credible, Compassionate News and Relatable Stories to the ALS Community

Searching for Information, a Media Resource Offers Credible, Compassionate News and Relatable Stories to the ALS Community

by Target ALS | May 27, 2020 | Trends

The ALS Association reports that at least 16,000 people in the U.S. have the disease at any given time, and more than 5,000 Americans are diagnosed each year.  Anecdotal evidence shows that upon diagnosis, most of those patients and their family members immediately...
Under the Microscope: Fen-Biao Gao ofUMass Medical School Explains His Now-Funded Project Targeting Biomarkers and Disease Modifiers for ALS and FTD

Under the Microscope: Fen-Biao Gao ofUMass Medical School Explains His Now-Funded Project Targeting Biomarkers and Disease Modifiers for ALS and FTD

by Target ALS | May 12, 2020 | Inspiring Stories

When Target ALS and The Association for Frontotemporal Degeneration (AFTD) put out a funding call late last year, the goal was to identify projects that the two organizations could jointly support. The scope of the projects involved targeting the discovery of...
« Older Entries

  • Challenge
  • Contact
  • Our Approach
  • Resources For Scientists
  • Donate
  • Call For Proposals
  • Funded Consortia
  • Annual Meeting
  • Privacy Policy
  • Credits

FOLLOW US

  • Instagram
  • Facebook
  • Instagram
  • Twitter

Support Target ALS

When you shop at smile.amazon.com,
Amazon donates.
Go to smile.amazon.com

The Target ALS (TALS) website is intended for informational purposes only. Opinions expressed may not be that of TALS or its employees. For more information about our digital policies, click here.

AmazonSmile and the AmazonSmile logo are trademarks of Amazon.com, Inc. or its affiliates

© 2022 Target ALS Foundation, Inc.
Target ALS Foundation
P.O. Box 1598
New York, NY 10101
(332) 333-4140
Steck Insights WordPress Consulting